Insulet Corp (PODD)
174.43
+1.01
(+0.58%)
USD |
NASDAQ |
May 03, 16:00
174.46
+0.03
(+0.02%)
After-Hours: 20:00
Insulet Gross Profit (Quarterly): 361.20M for Dec. 31, 2023
Gross Profit (Quarterly) Chart
Historical Gross Profit (Quarterly) Data
Date | Value |
---|---|
December 31, 2023 | 361.20M |
September 30, 2023 | 293.30M |
June 30, 2023 | 264.90M |
March 31, 2023 | 240.50M |
December 31, 2022 | 217.30M |
September 30, 2022 | 188.30M |
June 30, 2022 | 190.30M |
March 31, 2022 | 209.70M |
December 31, 2021 | 213.20M |
September 30, 2021 | 188.70M |
June 30, 2021 | 182.70M |
March 31, 2021 | 167.50M |
December 31, 2020 | 161.10M |
September 30, 2020 | 151.80M |
June 30, 2020 | 142.50M |
March 31, 2020 | 126.90M |
December 31, 2019 | 134.10M |
September 30, 2019 | 123.10M |
June 30, 2019 | 116.40M |
March 31, 2019 | 106.70M |
December 31, 2018 | 110.34M |
September 30, 2018 | 101.97M |
June 30, 2018 | 82.07M |
March 31, 2018 | 75.82M |
December 31, 2017 | 79.54M |
Date | Value |
---|---|
September 30, 2017 | 73.62M |
June 30, 2017 | 64.64M |
March 31, 2017 | 59.40M |
December 31, 2016 | 60.94M |
September 30, 2016 | 55.64M |
June 30, 2016 | 50.46M |
March 31, 2016 | 44.05M |
December 31, 2015 | 41.99M |
September 30, 2015 | 31.57M |
June 30, 2015 | 30.52M |
March 31, 2015 | 29.19M |
December 31, 2014 | 20.51M |
September 30, 2014 | 38.04M |
June 30, 2014 | 35.76M |
March 31, 2014 | 32.81M |
December 31, 2013 | 33.02M |
September 30, 2013 | 27.40M |
June 30, 2013 | 26.83M |
March 31, 2013 | 25.16M |
December 31, 2012 | 25.32M |
September 30, 2012 | 24.39M |
June 30, 2012 | 22.33M |
March 31, 2012 | 20.30M |
December 31, 2011 | 20.08M |
September 30, 2011 | 18.56M |
Gross Profit Definition
Gross profit is the difference between sales and the cost of goods sold. Revenues (aka Sales) less Cost of Goods Sold (COGS) is a company's gross profit. For many companies, cost of goods sold is a substantial portion of expenses.
Gross Profit (Quarterly) Range, Past 5 Years
116.40M
Minimum
Jun 2019
361.20M
Maximum
Dec 2023
193.34M
Average
188.30M
Median
Sep 2022
Gross Profit (Quarterly) Benchmarks
Abbott Laboratories | 5.501B |
Stryker Corp | 3.333B |
Tandem Diabetes Care Inc | 93.30M |
Becton Dickinson & Co | 2.304B |
ResMed Inc | 692.78M |